IGC CIK: 1326205

IGC Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.8
FY22:
−7.46
FY23:
−7.05
FY24:
−5.20
FY25:
−4.80
Change from FY21 to FY25
millions USD
FY21:
3.39
FY22:
−0.74
FY23:
−0.24
FY24:
−0.32
FY25:
−0.44
Change from FY21 to FY25
millions USD
FY21:
14.7
FY22:
4.14
FY23:
0.10
FY24:
3.52
FY25:
4.45
millions USD
FY21:
7.29
FY22:
−4.09
FY23:
−7.26
FY24:
−2.00
FY25:
−0.79
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.3
FY22:
−7.70
FY23:
−7.36
FY24:
−5.34
FY25:
−4.91

All amounts in millions USD Data source:SEC EDGAR